The global wearable cardiac devices market is entering a strong growth phase as healthcare providers and consumers increasingly adopt connected technologies for continuous cardiovascular monitoring. According to Grand View Research, the market was valued at USD 4.2 billion in 2025 and is expected to reach USD 4.5 billion in 2026. It is projected to expand to USD 8.7 billion by 2033, representing a 9.7% CAGR between 2026 and 2033.

North America remained the leading regional market, accounting for more than 46.1% of global revenue in 2025. Meanwhile, Asia Pacific is anticipated to record the fastest growth during the forecast period. Increasing cardiovascular disease prevalence, wider deployment of connected healthcare technologies, and demand for continuous patient monitoring are creating favorable conditions for market expansion.

Market at a Glance

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

Key Market Trends

Several structural developments are supporting demand for wearable cardiac monitoring technologies:

• Asia Pacific is expected to demonstrate the fastest CAGR from 2026 to 2033, supported by expanding healthcare infrastructure, increasing digital health adoption, and a growing cardiovascular disease burden.
• The U.S. market is projected to experience significant growth throughout the forecast period as remote monitoring and connected cardiac care gain wider clinical acceptance.
• Diagnostic & monitoring devices represented the largest product category in 2025, capturing 46.9% of the global market.
• Integration of wearables with IoT-enabled healthcare platforms is improving the ability of clinicians to receive and analyze patient data remotely.
• Demand is increasing for technologies capable of providing real-time cardiac insights, automated alerts, and clinical decision support.

Download a free sample report or claim your copy of this full market intelligence report

What Is Driving Market Expansion?

Rising Cardiovascular Disease Burden

The increasing global incidence of cardiovascular diseases is one of the primary factors accelerating adoption of wearable cardiac devices. Conditions such as arrhythmia, atrial fibrillation, heart failure, hypertension, and coronary artery disease require ongoing monitoring, creating demand for technologies capable of collecting cardiac data outside traditional clinical settings.

Population aging and lifestyle-related risk factors—including obesity, diabetes, smoking, physical inactivity, and chronic stress—are further increasing the need for cardiovascular monitoring. In the U.S., for example, the Centers for Disease Control and Prevention reported 919,032 cardiovascular disease deaths in 2023, highlighting the substantial burden associated with heart-related conditions.

Wearable technologies such as Holter monitors, ECG patches, smartwatches with electrocardiogram functionality, and mobile cardiac telemetry systems allow cardiac activity and physiological parameters to be monitored continuously. Their ability to capture data in real-world environments can support earlier identification of abnormal heart rhythms and facilitate more proactive disease management.

Growing awareness of preventive cardiac care is also encouraging consumers and healthcare professionals to use wearable monitoring technologies for routine assessment. At the healthcare-system level, the potential to improve chronic disease management and reduce avoidable hospital visits is strengthening the business case for these solutions.

Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs.

Remote Monitoring and AI Create New Opportunities

The expansion of remote patient monitoring (RPM) is another important contributor to market growth. Hospitals, specialty clinics, ambulatory care facilities, and home healthcare providers are increasingly adopting decentralized care models that enable patients to be monitored beyond conventional healthcare facilities.

Connected wearable cardiac devices can transmit information such as ECG readings, heart rate variability, oxygen saturation, and arrhythmia notifications to healthcare professionals through digital platforms. This enables clinicians to identify potential changes in a patient's condition and intervene more proactively.

The convergence of wearable sensors and artificial intelligence is creating additional opportunities. In November 2025, Yale researchers demonstrated the potential of AI to identify structural heart disease using a smartwatch's single-lead ECG sensor. In a study involving 600 patients, the AI system achieved 86% sensitivity and 87% specificity, approaching the diagnostic performance of conventional 12-lead ECG testing. Such developments could support broader early screening and expand the clinical applications of consumer-grade wearable cardiac technologies.

Competitive Landscape

The wearable cardiac devices market includes established medical-device manufacturers and specialized digital cardiac monitoring companies competing through product innovation, connected monitoring capabilities, clinical validation, and strategic technology development.

Key companies profiled in the market include:

• Medtronic
• Abbott
• Boston Scientific Corporation
• GE HealthCare
• Koninklijke Philips
• ZOLL Medical Corporation
• iRhythm Technologies, Inc.

Explore the full list of profiled companies operating in this market with recent strategic initiatives

Explore our dedicated business services:

• S. Healthcare Facility Mapping & Intelligence Portal – Claims analytics (MS-DRG, service lines, ICD-10 outpatient, APC reimbursement, CPT-level) plus hospital-level financials (balance sheet, income statement, uncompensated care, financial health dashboards), covering 25,000+ healthcare facilities — including 7,000+ hospitals, independent pharmacies, freestanding EDs, concierge physicians, and ASCs.
• Brainshare Consulting – End-to-end business consulting services including Opportunity assessment, GTM support, Competitive intelligence, and Consumer Analytics.
• Custom Research – Get a market intelligence report tailored to your specific requirements and aligned with your business goals.
• Consumer Insights – Capture real, evolving consumer sentiment and behavior to help you make data driven strategies.
• Horizon Databooks – Access the world’s largest portal of Market Reports & Statistics
• Investment Insights – Make investment decisions with data driven insights, powered by domain and technology
• Signal (Pricing Intelligence) - Commodity price intelligence to drives strategic advantage.

About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.